Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Thomson, S. P.    Jiang, N.-S.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Incremental Value of the Leukocyte Differential and the Rapid Creatine Kinase-MB Isoenzyme for the Early Diagnosis of Myocardial Infarction

Stephen P. Thomson; Raymond J. Gibbons; Peter A. Smars; Vera J. Suman; Robert V. Pierre; Paula J. Santrach; and Nai-Siang Jiang

1 March 1995 | Volume 122 Issue 5 | Pages 335-341

Objective: To test whether automated measurements of cortisol-induced changes in the leukocyte differential can provide an early marker of myocardial infarction, especially when combined with the rapid creatine kinase-MB isoenzyme.

Design: A prospective, blinded study of these measurements at the time of initial assessment in the emergency department.

Setting: Large multispecialty clinic hospital.

Patients: 511 consecutive patients presenting to the emergency department with chest pain. One hundred twenty-seven patients with infection, trauma, or metastatic cancer or receiving myelosuppressive or glucocorticoid therapy were excluded.

Measurements: Automated leukocyte differentials, rapid creatine kinase-MB levels, cortisol levels, and routine clinical measurements.

Results: Of 69 patients with myocardial infarction, only 39% had diagnostic electrocardiographic ST-segment elevation. ST-segment elevation had a specificity of 99% and a positive predictive value of 93%. A relative lymphocytopenia (lymphocyte decrease <20.3%) or elevated rapid creatine kinase-MB level (>4.7 ng/mL) was more sensitive than ST-segment elevation (sensitivities of 58% and 56%, respectively) but less specific (specificities of 91% and 93%, respectively). The presence of both a relative lymphocytopenia and an elevated rapid creatine kinase-MB level had a sensitivity of 44%, a specificity of 99.7%, and a positive predictive value of 97% (95% CI, 80% to 99%). Both a relative lymphocytopenia and an elevated rapid creatine kinase-MB level were independent (P < 0.001) predictors of infarction in patients without ST-segment elevation. If myocardial infarction was suspected by the presence of both abnormal markers or ST-segment elevation, the sensitivity for early diagnosis increased from 39% (ST elevation alone) to 65% (CI, 52% to 76%); the specificity was 99%; and the positive predictive value was 94% (CI, 82% to 98%).

Conclusions: The presence of both a relative lymphocytopenia and an elevated rapid creatine kinase-MB level was an accurate early marker of myocardial infarction that appeared to improve the sensitivity of early diagnosis compared with that of ST-segment elevation alone.

Author and Article Information

From Mayo Clinic and Mayo Foundation, Rochester, Minnesota.
Requests for Reprints: Raymond J. Gibbons, MD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Acknowledgments: The authors thank the nurses and physicians of the emergency department and inpatient cardiovascular units, the technical staff of the laboratories, and Drs. Hugh C. Smith and Robert L. Frye for their review of the questionable cases.

This article has been cited by other articles:

				Z. Yang, Y.-J. Day, M.-C. Toufektsian, Y. Xu, S. I. Ramos, M. A. Marshall, B. A. French, and J. Linden Myocardial Infarct-Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes Circulation, November 7, 2006; 114(19): 2056 - 2064. [Abstract] [Full Text] [PDF]

				B. D. Horne, J. L. Anderson, J. M. John, A. Weaver, T. L. Bair, K. R. Jensen, D. G. Renlund, J. B. Muhlestein, and Intermountain Heart Collaborative (IHC) Study Grou Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk? J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1638 - 1643. [Abstract] [Full Text] [PDF]

				B. S. Coller Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene? Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 658 - 670. [Abstract] [Full Text] [PDF]

				Y. N. A. Nabah, T. Mateo, R. Estelles, M. Mata, J. Zagorski, H. Sarau, J. Cortijo, E. J. Morcillo, P. J. Jose, and M.-J. Sanz Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines Circulation, December 7, 2004; 110(23): 3581 - 3586. [Abstract] [Full Text] [PDF]

				D. N. Reddan, P. S. Klassen, L. A. Szczech, J. A. Coladonato, S. O'Shea, W. F. Owen Jr, and E. G. Lowrie White blood cells as a novel mortality predictor in haemodialysis patients Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1167 - 1173. [Abstract] [Full Text] [PDF]

				K. Karnicki, W. G. Owen, R. S. Miller, and R. D. McBane II Factors Contributing to Individual Propensity for Arterial Thrombosis Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1495 - 1499. [Abstract] [Full Text] [PDF]

				A. Blum, S. R. Ommen, S. P. Thomson, and R. J. Gibbons Role of Lymphocytes in Heart Disease • Response Circulation, October 13, 1998; 98 (15): 1587 - 1590. [Full Text] [PDF]

				S. R. Ommen, D. O. Hodge, R. J. Rodeheffer, C. G. A. McGregor, S. P. Thomson, and R. J. Gibbons Predictive Power of the Relative Lymphocyte Concentration in Patients With Advanced Heart Failure Circulation, January 13, 1998; 97(1): 19 - 22. [Abstract] [Full Text] [PDF]

				Quickening Acute MI Diagnosis with Newer Markers Journal Watch Cardiology, April 1, 1995; 1995(401): 4 - 4. [Full Text]